2015
DOI: 10.1016/j.cherd.2015.04.018
|View full text |Cite
|
Sign up to set email alerts
|

Dissolution and solid state behaviours of carbamazepine-gluconolactone solid dispersion powders: The potential use of gluconolactone as dissolution enhancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 25 publications
1
9
0
1
Order By: Relevance
“…The drug’s peak intensities reacted in inverse proportion to the concentration of the excipients, and proportionally to a mount of the drug, i.e., for higher drug-excipient ratios, the amount of drug was less, therefore, the drug peak intensities were reduced. A similar phenomenon occurred in the literature, supporting the explanation that, when the concentration of carriers in solid dispersion formulations of carbamazepine-gluconolactone increased to 1:4, the intensity of the drug peak significantly reduced, and it was similarly explained that this could be due to the presence of less carbamazepine in these samples [ 29 ]. Dissolution studies supported this phenomenon as the dissolution rate was higher when the excipients ratio was increased.…”
Section: Resultssupporting
confidence: 83%
See 2 more Smart Citations
“…The drug’s peak intensities reacted in inverse proportion to the concentration of the excipients, and proportionally to a mount of the drug, i.e., for higher drug-excipient ratios, the amount of drug was less, therefore, the drug peak intensities were reduced. A similar phenomenon occurred in the literature, supporting the explanation that, when the concentration of carriers in solid dispersion formulations of carbamazepine-gluconolactone increased to 1:4, the intensity of the drug peak significantly reduced, and it was similarly explained that this could be due to the presence of less carbamazepine in these samples [ 29 ]. Dissolution studies supported this phenomenon as the dissolution rate was higher when the excipients ratio was increased.…”
Section: Resultssupporting
confidence: 83%
“…All drug vehicles formulas showed more than 55% release within 30 min and by the end of this test, after 90 min the dissolution extents were as follows: (drug-cyclodextrin 1:5 (99.79%)), (drug: trehalose 1:2 (99.69%)), (drug: gluconolactone 1:2 (97.85%)). Gluconolactone has been used to be a potential hydrophilic carrier to improve the dissolution rate of a hydrophobic drug such as carbamazepine, using physical mixtures and solid dispersion formulations [ 29 ]. Moreover, gluconolactone improved the dissolution rate of a poorly water soluble piroxicam [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…This suggested that the long grinding time (60 min) induced some degree of polymorphism in the sample (Figure 6a). Pure CBZ displayed a melting peak at 176 ºC, followed by an exothermic peak at 179 ºC (an indication of solid-solid transformation of polymorphic form III to I) and then a sharp endothermic peak at 192 ºC (melting of form I) [38]. These processes were also evident in the ground samples.…”
Section: Solid State Characterization Co-ground Samples and Physical mentioning
confidence: 60%
“…Dissolution tests 22 for cilostazol-free base, cilostazol mesylate, and cilostazol besylate were carried out in triplicate at 37°C±0.5°C using the basket method in a dissolution tester (708-DS; Agilent Technologies, Santa Clara, CA, USA). Hard gelatin capsules, “5” size (Capsugel, Morristown, NJ, USA), were filled with the accurately weighed samples equivalent to 20.0 mg of cilostazol.…”
Section: Methodsmentioning
confidence: 99%